Pharmesis International Ltd.

S$0.09As of Sun 8 Nov 2026, 12:00 UTC
SGX:BFKHealthcare
Country Singapore
PE (Fwd) •••
TSR 10Y CAGR (13.70%)
Div yield 11.11%
ROE (13.09%)
Pharmaceutical Preparations
Beta (5Y) (1.18)
PE TTM —
TSR TTM (76.61%)
Mkt cap S$2.853M
ROIC (13.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.117
29.46%
(86.08%)
Hold 1|1|11|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
—
—
—
—
(4.40%)
2.30%
0.83%
7.94%
Revenue¥M
0.201
0.213
0.216
0.226
10.93%
14.26%
11.35%
10.42%
Peers (US$2.225M)
Cap (US$)
PE
2.366M
—
Capital
TTM
5Y
10Y
Leveragex
0.347
(0.019)
(0.018)
EBIT/Intx
0.778
0.393
0.421
Own earn%
(119.74)
37.88
39.92
Sh yield%
34.32
12.01
13.55
Owners
Insiders/Inst%
10.38
45.37
Short interest%
4.29
SBC / revenue%
0.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
21–25
$1 testx
—
Incr. ROIC%
14